GSK last month announced that Blenrep had succeeded in improving overall survival in the trial, called DREAMM-7. The detailed ...

For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in ...

A GSK medicine that was pulled from the market after failing its confirmatory test in multiple myeloma has new data from a Phase 3 study evaluating it as an earlier line of treatment, and the ...

GSK (GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer (PFE) and Shionogi as ...

GSK announces success of their drug Blenrep at reducing the risk of death in patients diagnosed with multiple myeloma.

The collaboration deal, which could be worth hundreds of millions of dollars, is a “pivotal moment” for Muna Therapeutics, a ...

GSK & MMV announce first single-dose medicine for P. vivax malaria, tafenoquine prequalified by WHO and included in WHO guidelines: London, UK Friday, December 6, 2024, 15:00 Hrs ...

GSK is hosting the third annual RespiVerse Meeting in Bangkok, Thailand. The event brings together renowned international ...

In 2019, evidence showed that an impurity in drug degrades over time to form probable carcinogenic compound. Ranitidine is ...

London open The FTSE 100 is expected to open 12 points lower on Monday, having closed down 0.14% on Friday at 8,300.33.